Want to see DMAC full AI Analyst Report?
Compare Diamedica Therapeutics (DMAC) vs. Competitors
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| DMACDiamedica Therapeutics | $9.25 | $498.81M | -12.85 | 32.14% | Moderate Buy | DMAC | ||||
| TVRDTvardi Therapeutics | $0.79 | $10.58M | -0.28 | -83.00% | Moderate Buy | DMAC vs TVRD | ||||
| CAPRCapricor Therapeutics | $6.38 | $370.93M | -2.60 | 2.74% | Moderate Buy | DMAC vs CAPR | ||||
| RCKTRocket Pharmaceuticals | $2.44 | $267.85M | -15.25 | -34.05% | Moderate Buy | DMAC vs RCKT | ||||
| BNTCBenitec Biopharma | $8.74 | $304.93M | -8.92 | -45.95% | Strong Buy | DMAC vs BNTC | ||||
| ANNXAnnexon Biosciences | $4.05 | $767.80M | -3.49 | 38.23% | Strong Buy | DMAC vs ANNX |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DMAC | Diamedica Therapeutics | 9.25 | 2.45 | 36.03% | |
| TVRD | Tvardi Therapeutics | 0.79 | -3.72 | -82.44% | |
| CAPR | Capricor Therapeutics | 6.38 | 0.31 | 5.11% | |
| RCKT | Rocket Pharmaceuticals | 2.44 | -1.12 | -31.46% | |
| BNTC | Benitec Biopharma | 8.74 | -7.12 | -44.89% | |
| ANNX | Annexon Biosciences | 4.05 | 0.88 | 27.76% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts